We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Synthetic Reagents Improve Sensitivity and Specificity of Immunoassays

By LabMedica International staff writers
Posted on 30 Dec 2009
Synthetic reagents enhance sensitivity and specificity in enzyme-linked immunosorbent assays (ELISAs), rapid tests, and other immunoassays by decreasing nonspecific binding and stabilizing antibody-antigen complexes.

The wholly synthetic biocompatible bovine serum albumin (BSA) substitutes provide more effective blocking than BSA and generally improve overall signal to noise. More...
In addition, because they are synthetic, the reagents do not require any special handling normally associated with animal-derived materials and offer consistent lot-to-lot performance.

Supplied by B-Bridge International (Mountain View, CA, USA), the Biolipidure reagents are not susceptible to degradation and protease digestion, because they are nonbiological polymers. These polymers are extremely stable at high temperature and over multiple freeze-thaw cycles. This characteristic increases the robustness of reagents containing these compounds, enables antibodies to remain functional longer, and extends the shelf life of immunoassay kits.

The basic Biolipidure monomer contains a functional side group, which introduces some variability to the different polymers. The specific molecular weights, hydrophilicity-hydrophobicity, and ionic properties of the side groups produce a range of Biolipidure reagents whose secondary characteristics vary.

Because they are completely synthetic, Biolipidure reagents do not require any special handling normally associated with animal-derived materials and there is negligible lot-to-lot variation. There is no need to optimize for each lot and purchase large amounts of a single lot to obtain consistent results.

Related Links:

B-Bridge International


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.